Bladder cancer: features of epidemiology and indicators of specialized care delivery

Authors

DOI:

https://doi.org/10.26641/2307-0404.2021.2.234731

Keywords:

bladder cancer, prevalence, morbidity, occupational health examination, indicators of specialized care delivery

Abstract

The work is based on the materials of official statistical reporting, the analysis of which was carried out for 10 years, divided into two five-year periods (2009-2013 and 2014-2018). Absolute and intensive rates of morbidity and distribution of bladder cancer of the adult population of Ukraine in the regional aspect, taking into account sex were studied, the basic indicators of the prevalence of pathology were analyzed as well. The revealed unfavorable situation is characterized by a steady increase in morbidity and prevalence at a slower pace during 2014-2018. It is noteworthy the high level of morbidity in men, which is growing against the background of its stabilization among women. At the same time, there was noted the tendency in the reduced number of newly diagnosed patients during professional examinations (in 2018-16.9% against 18.0% in 2014) with diagnosis at stages I-II (72.2% vs. 74.79%), wherein every fifth has stage III-IV. With a tendency to increase in the number of registered patients ≥ 5 years (59.1% vs. 56.5%), the death rate did not change significantly within a year from the time of diagnosis (14.7% vs. 15.6%, respectively). In the structure of specialized care, (65% are patients with the first diagnosis), surgical method accounted for 37-40% by years, the combined was second (up to 20% by years), then radiation and chemotherapy, which together did not exceed 5.0%. Areas with high or low relative rates in relation to the average Ukrainian indicators for all parameters studied were identified. In the presence of regional differences, there is a need for in-depth studies of the state of the issue, including the quality and organization of care.

References

Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Kyiv: Small print; 2006. р. 558. Russian.

Starchenko II, Babenko VI, Prilutsky OK, Sidorenko MI, Starchenko OV. [Some epidemiological and clinical-morphological features of bladder cancer. New¬sletter of problems of biology and medicine]. 2018;2(43):336-9.

doi: https://doi.org/10.29254/2077-4214-2018-1-2-143-336-339

Zhumaniozov MM. [Results of surgical treatment of patients with bladder cancer]. Biology and integrative medicine. 2018;9(26):63-71. Russian.

Karyakin OB. [Bladder cancer: what's new in 2019 – 2020]. Oncourology. 2020;16(4):147-54. Russian. doi: https://doi.org/10.17650/1726-9776-2020-16-4-147-154

Lopoch SN, Chubenko AV, Babych PN. [Statistical methods in medical and biological research using EXCEL]. Kyiv: Morion, 2001. p. 408. Ukrainian.

Chernyshev IV, Perepechin DV, Samsonov YuV, et al. [Nonadjuvant systemic chemotherapy in the com¬bined treatment of locally advanced bladder cancer]. Medical Bulletin of Bashkortostan. 2013;8(2):176-8. Russian.

Odarchenko SP. [Current trends in lichuvanny cancer of sectional mikhura]. Men's health. 2014;4(51):124-6. Ukrainian.

Movchan KN, Chernov KE, Khizha VV, Zharkov AV, Artyushin BS, Chernova AYu. [Evaluation of the quality of treatment of patients with bladder cancer by the parameters of their survival]. Malignant tumors. 2019;9(3-S1):99-100. Russian.

Saydakova NO, Startseva LM, Kononova GЕ, Kravchuk NG. [The main indicators of urological assis¬tance in Ukraine for 2018-2019 rock: vidomche vidannya; Ministry of Health of Ukraine; State Institution "Institute of Urology of the National Academy of Medical Sciences of Ukraine"; DZ Center for Medical Statistics of the Ministry of Health of Ukraine]. Kyiv: Polium; 2020. p. 128. Ukrainian.

Schepotin IB. [Bulletin of the national chancellor-registry of Ukraine]. Kyiv; 2014;15:124. Ukrainian.

Fahmy O, Khairul-Asri M G, Schubert T, et al. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical custectomy with or without neoadjuvant chemotherahy for muscle-invasive bladder cancer. Urol Oncol. 2018;36(2):43-43. doi: https://doi.org/10.1016/j.urolonc.2017.10.002

Knoedler J, Frank I. Organ-sparing surgery in urology: partial cystectomy. Curr. Opin. Urol. 2015;25:111-5. doi: https://doi.org/10.1097/MOU.0000000000000145

Alfred Witjes J, et al. Updated 2018 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur. Urol. doi: https://doi.org/10.1016/j.eururo.2016.06.020

Published

2021-06-18

How to Cite

1.
Saidakova N, Yatsina О, Grodzinsky V, Stus V, Polion M, Shiloh V, Коnonova G. Bladder cancer: features of epidemiology and indicators of specialized care delivery. Med. perspekt. [Internet]. 2021Jun.18 [cited 2022May18];26(2):173-80. Available from: http://journals.uran.ua/index.php/2307-0404/article/view/234731

Issue

Section

SOCIAL MEDICINE